GLOBAL EEG BIOSENSOR MARKET

INTRODUCTION

EEG biosensor is a technique for capturing an electrogram of the brain's spontaneous electrical activity. It has been demonstrated that the biosignals picked up by EEG are postsynaptic potentials of pyramidal neurons in the neocortex and allocortex. The International 10-20 system, or variants of it, is commonly used to implant the EEG electrodes along the scalp, making it a minimally invasive procedure.

The term "intracranial EEG" is occasionally used to refer to electrocorticography, which involves surgically implanting electrodes. Visual inspection of the trace or quantitative EEG analysis are the two methods used most frequently in clinical interpretation of EEG recordings.

The EEG bioamplifier and electrodes' voltage measurements enable the assessment of typical brain activity. The recordings made by the electrodes on the scalp's surface vary depending on their direction and proximity to the source of the electrical activity, which is a group of neurons in the underlying brain tissue.

Moreover, intermediate tissues and bone, which behave similarly to resistors and capacitors in an electrical circuit, affect the value reported. This indicates that not all neurons will contribute equally to an EEG signal, with an EEG mostly reflecting the activity of cortical neurons close to the scalp electrodes.

The base of the cortical gyrus, the mesial walls of the main lobes, the hippocampus, the thalamus, and the brainstem are deep brain areas that are farther from the electrodes and do not immediately contribute to an EEG.

GLOBAL EEG BIOSENSOR MARKET SIZE AND FORECAST

 The Global EEG biosensor market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

NEW PRODUCT LAUNCH

Leading consumer neurotechnology and meditation company Interaxon Inc. haslaunched the release of their VR Software Development Kit and a new EEG biosensor headband that is compatible with all popular VR head-mounted displays and is based on Interaxon's Muse S second-generation EEG meditation & sleep headband.

Using their award-winning biosensing technology in VR and AR applications, Interaxon hopes to offer strategic partnership prospects for advancements in brain health with this launch.The integration of biosensor data from wearables into digital health experiences has provided consumers with new levels of personalized insights.

Moving toward a more integrated future where personalized recommendations are unified across a variety of wellness applications, Interaxon believes web3 has the potential to create a more streamlined approach to digital health and data management for end-users that also leverages real-time biofeedback for powerful wellness interventions.

The rise in telehealth services amid the pandemic, for example, presents an opportunity for biosensor data and real-time biofeedback to be utilized to transform the digital health and wellness space by improving the overall remote healthcare experience for providers and users alike.

COMPANY PROFILE

• Advanced Brain
• BioSemi
•  EGI
• NeuroScan
•  NeuroSky 
• Brain Products
• NeuroScan

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many  EEG biosensor are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global  EEG biosensor and key vendor selection criteria
3. Where is the  EEG biosensor manufactured? What is the average margin per unit?
4. Market share of Global  EEG biosensor market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global  EEG biosensor in-house
6. key predictions for next 5 years in Global  EEG biosensor market
7. Average B-2-B  EEG biosensor market price in all segments
8. Latest trends in  EEG biosensor market, by every market segment
9. The market size (both volume and value) of the  EEG biosensor market in 2023-2030 and every year in between?
10. Production breakup of  EEG biosensor market, by suppliers and their OEM relationship